1 reports of this reaction
3.8% of all CAMPHOR (SYNTHETIC) reports
#16 most reported adverse reaction
MYOCARDIAL INFARCTION is the #16 most commonly reported adverse reaction for CAMPHOR (SYNTHETIC), manufactured by Kaz USA, Inc. There are 1 FDA adverse event reports linking CAMPHOR (SYNTHETIC) to MYOCARDIAL INFARCTION. This represents approximately 3.8% of all 26 adverse event reports for this drug.
Patients taking CAMPHOR (SYNTHETIC) who experience myocardial infarction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MYOCARDIAL INFARCTION is moderately reported among CAMPHOR (SYNTHETIC) users, representing a notable but not dominant share of adverse events.
In addition to myocardial infarction, the following adverse reactions have been reported for CAMPHOR (SYNTHETIC):
The following drugs have also been linked to myocardial infarction in FDA adverse event reports:
MYOCARDIAL INFARCTION has been reported as an adverse event in 1 FDA reports for CAMPHOR (SYNTHETIC). This does not prove causation, but indicates an association observed in post-market surveillance data.
MYOCARDIAL INFARCTION accounts for approximately 3.8% of all adverse event reports for CAMPHOR (SYNTHETIC), making it a notable side effect.
If you experience myocardial infarction while taking CAMPHOR (SYNTHETIC), contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.